CIAM
PFE icon

Caitong International Asset Management’s Pfizer PFE Stock Holding History

Caitong International Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,634
Closed -$475K – 2269
2025
Q3 		$475K Buy
+18,634
New +$460K 0.33% 33
2025
Q1 		– Sell
-1,919
Closed -$50.9K – 2447
2024
Q4 		$50.9K Buy
+1,919
New +$52.1K 0.05% 477

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Caitong International Asset Management's PFE Position: Q4 2025 in Review

Caitong International Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 18,634 shares — an estimated $475K sold.

Caitong International Asset Management first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $475K in Q3 2025. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Caitong International Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 18,634 Pfizer shares in Q4 2025, an estimated $475K.
  • Caitong International Asset Management first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
  • Caitong International Asset Management's Pfizer position peaked at $475K in Q3 2025.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.